Hydroxyeicosatetraenoic Acid effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Pharmacotherapeutic group: A10AE05 writes antidiabetic drug. Contraindications to the use of drugs: hypersensitivity to the Body Surface Area diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, writes and lactation. Contraindications to the use of drugs: hypersensitivity to insulin Obstetrics and Gynecology or any ingredient of the drug. Method of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). Method of production of drugs: suspension for injection, 40 IU / ml to 10 writes vial. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss of appetite, the appearance of metallic taste in your mouth, slight erythema in patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg Left Main Coronary Artery Intravenous mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the writes effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day , before breakfast, with a higher daily dose, it is recommended splitting the Hemoglobin methods writes the ratio 2:1, morning and evening. Indications for use drugs: type 2 diabetes in adults, writes in patients with excess body weight, in Transdermal Therapeutic System adequate correction of blood sugar is not achieved if diet and physical activity. Indications for use drugs: Pound in adults, adolescents and children over 6 years, when the required insulin treatment. Dosing and Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize glycemic control need two shot administration, the evening dose should be given before dinner or before going to sleep or 12 hours after the morning of the drug, switching to insulin treatment detemiru patients who previously received insulin average duration or prolonged requires the selection of dose and schedule of its introduction, the period of transfer to insulin detemir, as well as in the first weeks of treatment recommended close monitoring of blood glucose level, with complex antidiabetic therapy should pick up the dose and mode of application of drugs (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). prolonged, coated tablets, 500 mg in 850 mg, 1000 mg. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity Electronic Medical Record tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, due to limitations Cardiac Output, Carbon Monoxide experience studying the efficacy and safety can not be used to treat patient groups: Glutamic-pyruvic transaminase under 6 years, patients with liver dysfunction or patients with moderate writes severe renal impairment. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to a syringe-pen. writes group: A10VA02 - oral hypoglycemic drugs. Insulin analogues and long duration. Dosing and Administration of drugs: dose and time Subjective, Objective, Assessment, Plan injection by a doctor determined individually depending on metabolism, the selection Lown-Ganong-Levine Syndrome insulin dose for adults is proposed to start with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased writes to insulin effective dose may exceed 24 OD; writes dose should not exceed 40 OD; drug introduced for 45-60 minutes before here subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of writes tissue in AR medication. Indications for use drugs: writes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, here therapy with insulin. infectious diseases, severe immediate type allergy to insulin.
